《4 Stocks to Buy Before the End of 2026!》
AI 摘要 · BillionToOne 值得买入:其 QCT 平台的单分子计数带来传统诊断普遍无法企及的灵敏度;说话者预计对增长最重要的肿瘤液体活检同比增长 96%,年化规模约 6800 万美元。营收超市场预期约 50%,EPS 超过预期的两倍以上,产前业务收入增长 41%,连续第五个季度实现正的 GAAP 营业利润,同时自由现金流约 900 万美元、现金 5.62 亿美元;12 月中旬推出的微小残留病灶检测是这一肿瘤业务布局的关键。
今天视频的最后一只股票,我要讲医疗保健板块的另一家公司,一个也许不太为人所知的名字。我想稍微换换花样。我们有时在评论中看到你们提到我们只谈科技股,所以我想稍微改变一下氛围。我们看看吧。
那么,BillionToOne,它的代码是 BLLN。
For the last stock in today's video, I'll be talking about another name in the healthcare sector, another name that is perhaps a little less well known. I'm trying to change things up a bit.
We sometimes see in the comments that you mention we're only talking about technology stocks, so I'm trying to change the atmosphere a little. We'll see. So, BillionToOne, its symbol is BLLN.